Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.
Anissa MessaaouiLucia HajselovaSylvie TenoutassePublished in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
The prevalence of anti-SARS-CoV-2 antibodies in children with newly diagnosed type 1 diabetes (20%) is similar to that found in children without diabetes in Belgium, a country severely affected by this pandemic.